Order results by:
| Issue | Title | |
| Vol 11, No 4 (2019) | Genetic risk factors for behavioral adverse reactions in epileptic patients taking levetiracetam | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... . The LEV-induced behavioral ADRs are related to SNV DBH rs1611115 that can be considered as one ..." | ||
| Online-first | GENETIC RISK FACTORS FOR THE DEVELOPMENT OF BEHAVIORAL ADVERSE DRUG REACTIONS IN PATIENTS WITH EPILEPSY TAKING LEVETIRACETAM | Abstract similar documents |
| A. A. Usoltseva, D. V. Dmitrenko, S. N. Zobova, E. N. Bochanova, N. A. Shnayder | ||
| "... with SNVs rs1800497 and rs1611115. Behavioral ADRs are associated with SNV rs1611115 of DBH gene, which can ..." | ||
| Vol 14, No 5 (2022) | Study of the role of carriage of single nucleotide variants of the IL-1β, TNFA, BDNF, NTRK-2 genes in the development and clinical features of temporal lobe epilepsy | Abstract PDF (Eng) similar documents |
| Yu. S. Panina, E. A. Domoratskaya, A. I. Paramonova, D. V. Dmitrenko | ||
| "... (ОНВ) генов, кодирующих белки нейровоспаления и нейродегенерации, в развитие ВЭ в Российской Федерации ..." | ||
| Vol 10, No 1S (2018): СПЕЦВЫПУСК: ЭПИЛЕПСИЯ | An open-label prospective clinical study of the efficacy and tolerability of brand-name and generic levetiracetam in the monotherapy of focal epilepsy in adults | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... with levetiracetam (LEV), a brand-name drug (bLEV; Keppra, UCB Pharma, Belgium) and its generic (gLEV; Epiterra ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Efficacy of generic levetiracetam (epiterra) in monotherapy for epilepsy in adult patients: preliminary results | Abstract similar documents |
| V. A. Karlov, P. N. Vlasov, I. A. Zhidkova | ||
| "... Objective: to evaluate the efficacy and tolerability of levetiracetam (LEV) (epiterra, TEVA ..." | ||
| Vol 13, No 3 (2021) | Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis | Abstract similar documents |
| A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider | ||
| "... Objective: to assess the predictors and prevalence of adverse drug reactions (ADRs) associated ..." | ||
| Vol 13, No 6 (2021) | Drug-induced parkinsonism | Abstract PDF (Eng) similar documents |
| T. M. Ostroumova, O. D. Ostroumova, A. S. Soloveva | ||
| "... treatment onset or increasing the dose of drugs that most often lead to such an adverse reaction (ADR). DIP ..." | ||
| Vol 15, No 3 (2023) | Parkinson’s disease. Focus on early stages | Abstract similar documents |
| E. A. Katunina, Z. A. Zalyalova, D. V. Pokhabov, M. Z. Ivanova, A. M. Semenova | ||
| "... (ADR), amantadines, MAO-B inhibitors. The mechanisms of ADR action, the possibility of their influence ..." | ||
| Vol 16, No 2 (2024) | Efficacy of antiparkinsonian therapy in tremor correction according to tremorography | Abstract similar documents |
| V. A. Bogacheva, D. V. Zakharov, V. A. Mikhailov | ||
| "... of four drugs in monotherapy: dopamine receptor agonists (ADR; pramipexole), levodopa (Tidomet forte ..." | ||
| Vol 15, No 6 (2023) | Effect of dopaminergic therapy on lacrimation in Parkinson's disease | Abstract similar documents |
| A. A. Pilipovich, O. V. Vorob'eva, S. A. Makarov, A. V. Kuchuk | ||
| "... agonists (ADR) (n=28) were assessed using Schirmer's test (to estimate tear flow), sialometry, Unified ..." | ||
| 1 - 10 of 10 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
